#Canadian study or re-identification of #AE data in Health Canada #database. http://t.co/UEuHl11Ky5
Re-identification risk from the Canadian adverse drug event database - an analysis and model: http://t.co/7irWTaQ7fK (1/3)
Re-identification risk from the Canadian adverse drug event database - an analysis and model: http://t.co/7irWTaQ7fK (1/3)
Re-identification risk from the Canadian adverse drug event database - an analysis and model: http://t.co/7irWTaQ7fK (1/3)
New risk model taking into account repeated attacks on a data set and cost of re-identification: http://t.co/7irWTaQ7fK (3/3)
Data release of Canadian adverse drug event data was part of federal court case - our empirical analysis: http://t.co/7irWTaQ7fK (2/3)
Re-identification risk from the Canadian adverse drug event database - an analysis and model: http://t.co/7irWTaQ7fK (1/3)
Evaluating the risk of patient re-identification from adverse drug event reports http://t.co/jOT9WhAwjB
plausibility .. is limited because of the financial and practical deterrent even for highly motivated adversaries. http://t.co/22WD7MwMFZ
Evaluating the risk of patient re-identification from adverse drug event reports: Khaled El Emam, Fi... http://t.co/NE9UIJQ9mW #HealthIT
plausibility .. is limited because of the financial and practical deterrent even for highly motivated adversaries. http://t.co/22WD7MwMFZ
Nice example of Data Intrusion Scenario simulation for De-identified Data re-identification risk assessment. http://t.co/EWfyDPyxNB
Nice example of Data Intrusion Scenario simulation for De-identified Data re-identification risk assessment. http://t.co/EWfyDPyxNB